Latest Licensing News

InFocus Group Holdings has secured $450,000 in a placement to fund the commercialisation of its AI-driven Codexa sweepstakes casino platform, targeting the US market with new compliance technology and patent applications.

Hawk Resources has obtained all necessary government approvals to begin exploration at its Olympus scandium project in Western Australia, targeting a significant scandium anomaly with plans to fast-track drilling.

Minbos Resources edges closer to operational readiness at Cabinda with a US$1.3 million initial drawdown from Banco de Fomento Angola and steel framework shipment underway for Phase 2 construction.

Yowie Group Limited cut its net loss to US$0.20 million in FY26 despite a 27.1% drop in revenue, driven by cost cuts, loan impairment reversals, and new product launches including the Yowie x NBA series.

TALi Digital (ASX:TD1) is raising up to $3.3 million through a Security Purchase Plan and Placement to fund its acquisition of Datasphere Analytics and advance its AI-driven education platform.

Provaris Energy has teamed up with Himile Heavy Industries to transition its hydrogen tank production from prototype to commercial scale, leveraging Himile's industrial manufacturing expertise and facilities in China.

Southern Hemisphere Mining has reported substantial new copper sulphide zones at its Llahuin project in Chile, reinforcing an exploration target of up to 340 million tonnes and setting the stage for further drilling and beneficiation work.

Nanoveu's EMASS division has been granted a US patent for a silicon accelerator that dramatically speeds up AI object detection, underpinning its next-gen ECS-DoT chip now in production at TSMC.

Osteopore Limited’s half-year results show an 8% revenue drop driven by currency effects, while losses widen 14% as the company invests heavily in product development and market growth.

Recce Pharmaceuticals narrowed its operating loss to AUD 15 million in FY26, progressing Phase 3 trials for its anti-infective RECCE 327 and securing key patents and commercial partnerships.

Advance ZincTek posted an 11% rise in FY26 profit before tax to $2.247 million on 12.6% higher sales, driven by AI integration and US market strength. The company is set to enter residential battery manufacturing in FY27, leveraging its zinc oxide expertise.

BLS Pharmaceuticals (ASX: BLS) reported a standout FY26 with revenue surging 161% to $74.2 million and net profit more than tripling to $15.4 million, driven by expanded manufacturing and major international contracts including a $50 million German supply deal.